title: Chapter 1: The management of erectile dysfunction: an AUA update.
authors.forename: Drogo K
authors.initials: DK
authors.lastname: Montague
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Jarow
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Broderick
authors.forename: Roger R
authors.initials: RR
authors.lastname: Dmochowski
authors.forename: Jeremy P W
authors.initials: JP
authors.lastname: Heaton
authors.forename: Tom F
authors.initials: TF
authors.lastname: Lue
authors.forename: Aaron J
authors.initials: AJ
authors.lastname: Milbank
authors.forename: Ajay
authors.initials: A
authors.lastname: Nehra
authors.forename: Ira D
authors.initials: ID
authors.lastname: Sharlip
mesh_terms: D015106:3',5'-Cyclic-GMP Phosphodiesterases; D035843:Biomedical Research / Q000639:trends; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D007172:Erectile Dysfunction / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D005544:Forecasting; D006801:Humans; D008297:Male; D015917:Penile Prosthesis; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010727:Phosphoric Diester Hydrolases; D014656:Vascular Surgical Procedures
chemical_list: D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human